Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **chloride channel protein family members**, collectively known as **chloride channels**, comprise several molecular families responsible for mediating the movement of chloride ions across cellular membranes. The main families include: #### Major Families: | Family | Example Members | Function | |--------|----------------|----------| | **CLC Family (Voltage-Gated)** | ClC‑0 through ClC‑7; ClC-Ka/Kb | Regulate electrical excitability; acidify organelles; kidney salt handling | | **CLIC Family (“Intracellular” Channels)** | CLIC1–6 | Regulate membrane potential and transepithelial transport | | **CFTR (“ABC Transporter” Channel)** | CFTR/ABCC7 | Epithelial fluid secretion; mutated in cystic fibrosis | | **Ligand-Gated Channels (“Neurotransmitter Receptors”)** | GABA(A), glycine receptors | Mediate synaptic inhibition | These proteins share a common function—selective passage of Cl- ions—but differ widely in structure and regulatory mechanisms. They play critical roles throughout physiology including neuronal signaling, muscle contraction relaxation cycles, epithelial fluid balance especially within kidneys/lungs/glands, cell volume regulation under osmotic stress conditions, and acidification processes within endosomes/lysosomes. Mutations or dysregulation cause diverse human diseases ranging from neuromuscular disorders to kidney tubulopathies to life-threatening lung disease such as cystic fibrosis. Because “chloride channel protein family member” is not a unique entity but rather refers generically to any one among dozens of related but distinct molecules with different tissue distributions/functions/disease associations/drug sensitivities,[4] precise identification at the gene/protein level is required when considering therapeutic targeting or clinical interpretation.[10]
Depends on subtype; general mechanisms include: - Channel blockers/inhibitors reduce chloride conductance. - Channel openers/potentiators increase activity. For ligand-gated types: * Positive allosteric modulators enhance gating by neurotransmitters. For CFTR: * Potentiators/correctors restore function in cystic fibrosis. For voltage-gated types: * Modulators alter gating kinetics or voltage sensitivity.[4]
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chloride channel protein (family member) (ClC (for CLC family members, e.g., ClC-1, ClC-2, etc.)).